7 F.4th 1201
D.C. Cir.2021Background
- Bellion Spirits produces vodka containing NTX and in 2016 petitioned TTB to permit label/advertising claims that NTX 'helps protect DNA from alcohol-induced damage' and 'reduces alcohol-induced DNA damage.'
- Bellion submitted 112 studies in support, did not file a COLA (label-approval) application, and disclaimed seeking label-specific approval; a third party later filed COLA applications with the same claims.
- TTB forwarded the petition to FDA, consulted FDA, and in May 2017 issued a 47-page ruling denying the petition as scientifically unsubstantiated and misleading; TTB found the proposed disclaimer inadequate.
- Bellion sued, sought to add extra evidence to the administrative record (denied), and claimed First Amendment and vagueness violations; the district court granted summary judgment for the government.
- The D.C. Circuit held TTB’s ruling was final agency action, the case was ripe, and affirmed summary judgment: the claims were inherently misleading, the COLA/approval scheme was constitutional, and the regulations were not unconstitutionally vague.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Final agency action / Ripeness | Ruling letter is advisory/non-final | Letter consummates decision and creates legal consequences (willfulness) | Letter is final; case is ripe |
| Supplementing the administrative record | District court abused discretion by excluding new expert evidence | Review is limited to materials before TTB absent unusual circumstances | Court did not err; no unusual circumstances to supplement |
| Delegation to FDA | TTB improperly delegated statutory authority to FDA | TTB permissibly consulted FDA and made its own decision | No unlawful delegation; TTB independently evaluated and adopted FDA analysis where appropriate |
| First Amendment (misleading commercial speech) | TTB’s prohibition violates free speech; de novo review required | Claims are inherently misleading and thus unprotected | Claims are unprotected: evidence insufficient; claims misleading |
| Prior restraint / COLA process | COLA preapproval is an unconstitutional prior restraint / vests unbridled discretion | COLA sets objective standards, deadlines, and appeal procedures | COLA scheme is adequately constrained and not an unconstitutional prior restraint |
| Vagueness (Fifth Amendment) | Regulations are vague and give inadequate guidance | Regulations give fair warning and allow administrative clarification | Facial vagueness challenge fails; regs give sufficient notice and process |
Key Cases Cited
- Cent. Hudson Gas & Elec. Corp. v. Pub. Serv. Comm’n of N.Y., 447 U.S. 557 (1980) (commercial-speech standard: lawful and non-misleading)
- Abbott Labs. v. Gardner, 387 U.S. 136 (1967) (ripeness/finality analysis)
- POM Wonderful, LLC v. FTC, 777 F.3d 478 (D.C. Cir. 2015) (agency review of misleading commercial claims)
- Pearson v. Shalala, 164 F.3d 650 (D.C. Cir. 1999) (regulatory ban on unsubstantiated health claims)
- Village of Hoffman Estates v. Flipside, 455 U.S. 489 (1982) (vagueness doctrine and role of administrative clarification)
- City of Lakewood v. Plain Dealer Publ'g Co., 486 U.S. 750 (1988) (limits on licensing discretion)
- Freedman v. Maryland, 380 U.S. 51 (1965) (prior restraint procedural safeguards)
- U.S. Telecom Ass'n v. FCC, 825 F.3d 674 (D.C. Cir. 2016) (vagueness review and administrative guidance)